Search details
1.
Phase II Trials of Iniparib (BSI-201) in Combination with Gemcitabine and Carboplatin in Patients with Recurrent Ovarian Cancer.
Oncologist
; 28(3): 252-257, 2023 03 17.
Article
in English
| MEDLINE | ID: mdl-36718018
Results
1 -
1
de 1
1
Next >
>>